TradingKey

关于 Anika Therapeutics Inc 公司

Anika Therapeutics, Inc. 是一家全球性关节保护公司。该公司在早期干预骨科护理领域创造和提供进步，包括骨关节炎 (OA) 疼痛管理、再生解决方案和运动医学领域。该公司专注于开发、制造和商业化其透明质酸 (HA) 技术平台上的产品。其 OA 疼痛管理产品系列包括 Monovisc 和 Orthovisc，其可注射的 HA、OA 疼痛管理产品旨在缓解骨关节炎引起的疼痛；以及 Cingal，其新型、下一代、单次注射 OA 疼痛管理产品，由其专有的交联 HA 材料与类固醇结合而成。其关节保护和修复产品系列包括利用 HA 的骨科再生解决方案产品组合，包括 Integrity，其用于肩袖和其他肌腱修复的新型透明质酸基支架。

公司简介

公司代码ANIK

公司名称Anika Therapeutics Inc

上市日期May 16, 1985

CEODr. Cheryl Renee Blanchard, Ph.D.

员工数量288

证券类型Ordinary Share

年结日May 16

公司地址32 Wiggins Ave

城市BEDFORD

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编01730-2315

电话17814579000

网址https://anika.com/

公司代码ANIK

上市日期May 16, 1985

CEODr. Cheryl Renee Blanchard, Ph.D.

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Glenn R. Larsen, Ph.D.

Independent Director

50.26K

+39.24%

Ms. Sheryl L. Conley

Independent Director

39.84K

+55.16%

Mr. William R. (Bill) Jellison

Independent Director

23.10K

+158.45%

Mr. Joseph H. (Joe) Capper

Independent Director

20.40K

+227.02%

Mr. Stephen D. (Steve) Griffin

Chief Financial Officer, Chief Operating Officer, Executive Vice President

9.07K

--

Mr. Matt Hall

Director, Corporate Development and Investor Relations

--

Mr. Ian McLeod

Chief Accounting Officer, Vice President, Treasurer

--

Mr. Gary P. Fischetti

Independent Director

--

Dr. Cheryl Renee Blanchard, Ph.D.

President, Chief Executive Officer, Director

--

Mr. David B. Colleran, J.D.

Executive Vice President, General Counsel, Secretary

--

名称

名称/职务

职务

持股

持股变动

Dr. Glenn R. Larsen, Ph.D.

Independent Director

50.26K

+39.24%

Ms. Sheryl L. Conley

Independent Director

39.84K

+55.16%

Mr. William R. (Bill) Jellison

Independent Director

23.10K

+158.45%

Mr. Joseph H. (Joe) Capper

Independent Director

20.40K

+227.02%

Mr. Stephen D. (Steve) Griffin

Chief Financial Officer, Chief Operating Officer, Executive Vice President

9.07K

--

Mr. Matt Hall

Director, Corporate Development and Investor Relations

--

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

OEM Channel

14.91M

56.97%

Commercial Channel

11.26M

43.03%

地区USD

名称

营收

占比

United States

16.36M

62.53%

Europe

5.80M

22.16%

Other

4.01M

15.31%

业务

地区

业务USD

名称

营收

占比

OEM Channel

14.91M

56.97%

Commercial Channel

11.26M

43.03%

股东统计

更新时间: 5月17日周六

持股股东

股东类型

持股股东

占比

Trigran Investments, Inc.

14.16%

Caligan Partners, LP

9.95%

BlackRock Institutional Trust Company, N.A.

6.64%

The Vanguard Group, Inc.

5.39%

Dimensional Fund Advisors, L.P.

4.26%

Other

59.59%

持股股东

占比

Trigran Investments, Inc.

14.16%

Caligan Partners, LP

9.95%

BlackRock Institutional Trust Company, N.A.

6.64%

The Vanguard Group, Inc.

5.39%

Dimensional Fund Advisors, L.P.

4.26%

Other

59.59%

股东类型

持股股东

占比

Hedge Fund

37.47%

Investment Advisor/Hedge Fund

27.11%

Investment Advisor

23.49%

Individual Investor

4.91%

Research Firm

1.57%

Pension Fund

0.77%

Bank and Trust

0.12%

Insurance Company

0.03%

Other

4.53%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

302

13.69M

95.46%

-1.42M

2025Q1

310

13.52M

94.22%

-1.59M

2024Q4

308

13.33M

91.05%

-2.02M

2024Q3

309

13.98M

94.53%

-1.95M

2024Q2

313

14.09M

95.06%

-2.05M

2024Q1

312

14.07M

96.09%

-1.66M

2023Q4

314

13.84M

94.50%

-1.88M

2023Q3

309

13.57M

92.73%

-2.13M

2023Q2

310

13.73M

93.04%

-2.32M

2023Q1

326

13.65M

93.27%

-2.92M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Trigran Investments, Inc.

2.04M

14.24%

+20.07K

+0.99%

Mar 31, 2025

Caligan Partners, LP

1.44M

10.01%

--

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

957.43K

6.68%

-49.29K

-4.90%

Mar 31, 2025

The Vanguard Group, Inc.

777.40K

5.42%

+12.13K

+1.59%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

613.97K

4.28%

-43.38K

-6.60%

Mar 31, 2025

Acadian Asset Management LLC

539.61K

3.76%

+63.90K

+13.43%

Mar 31, 2025

Boothbay Fund Management, LLC

529.50K

3.69%

--

Mar 31, 2025

Renaissance Technologies LLC

528.62K

3.69%

+100.00

+0.02%

Mar 31, 2025

BlackRock Financial Management, Inc.

522.01K

3.64%

+11.71K

+2.30%

Mar 31, 2025

Alta Fundamental Advisers LLC

470.97K

3.28%

-229.46K

-32.76%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.43%

Royce Quant Small-Cap Quality Value ETF

0.15%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.1%

iShares Micro-Cap ETF

0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

Avantis US Small Cap Equity ETF

0.02%

ProShares Hedge Replication ETF

0.01%

Global X Russell 2000 ETF

0.01%

ProShares UltraPro Russell2000

0.01%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.43%

Royce Quant Small-Cap Quality Value ETF

占比0.15%

SPDR SSGA US Small Cap Low Volatility Index ETF

占比0.1%

iShares Micro-Cap ETF

占比0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.02%

Avantis US Small Cap Equity ETF

占比0.02%

ProShares Hedge Replication ETF

占比0.01%

Global X Russell 2000 ETF

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

占比0.01%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Anika Therapeutics Inc

8.410USD

Anika Therapeutics Inc

8.410

概览

公司

财务